Co-Diagnostics Inc (CODX) Live Share Price, Invest From India

Co-Diagnostics Inc Stock Performance

as on March 31, 2026 at 6:59 am IST

Day's Low
Day's High
$1.68
Day's Price Range
$1.80
$1.69
0.59%
Downside
6.51%
Upside
52 Week's Low
52 Week's High
$1.66
52-Week Price Range
$46.50
$1.69
1.78%
Downside
2651.48%
Upside

Co-Diagnostics Inc share price movements today

Previous Close: $1.75
Open: $1.78
Volume: 699.6K
Day's Low - High: $1.68 - $1.80
52 Week Low - High: $1.66 - $46.50

Co-Diagnostics Inc Historical Returns

1 Month Return: -23.77 %
3 Month Return: -66.39 %
1 Year Return: -81.7 %
3 Year Return: -96.17 %
5 Year Return: -99.41 %

Co-Diagnostics Inc Stock Fundamentals & Key Indicators

Check Co-Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.31%

PE Ratio (TTM)

-1.21

Industry PE ratio

-4.138478964401295

PEG Ratio

EBITDA

-34.3M

Revenue (TTM)

507.9K

Profit Margin

0.00%

Return On Equity TTM

-62.12%

Co-Diagnostics Inc Stock Valuation

Track how Co-Diagnostics Inc P/E has moved over time to understand its valuation trends.

Co-Diagnostics Inc in the last 5 years

Overview
Trends

Lowest (-80.16x)

March 31, 2023

Industry (-4.14x)

March 31, 2026

Today (-1.21x)

March 31, 2026

Highest (170.90x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -1.21x

Co-Diagnostics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Co-Diagnostics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Co-Diagnostics Inc	SELL	$3.7M	-99.41%	-1.21	0.00%
Boston Scientific Corp.	BUY	$102.8B	62.82%	35.65	14.44%
Stryker Corporation	BUY	$125.4B	33.88%	38.89	12.92%
Medtronic Plc	BUY	$111.9B	-27.42%	24.34	13.00%
Abbott Laboratories	BUY	$180.7B	-14.99%	27.95	14.72%

See all

Stock Returns calculator for Co-Diagnostics Inc Stock including INR - Dollar returns

The Co-Diagnostics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Co-Diagnostics Inc investment value today

Current value as on today

₹20,159

Returns

-₹79,841

(-79.84%)

Returns from Co-Diagnostics Inc Stock

-₹81,808 (-81.81%)

Dollar Impact

₹1,967 (+1.97%)

Analyst Recommendation on Co-Diagnostics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Co-Diagnostics Inc. Average target price of $45

Co-Diagnostics Inc Share Price Target

Get share price movements and forecasts by analysts on Co-Diagnostics Inc.

What analysts predicted

96.24%UPSIDE

Target Price

$45

Current Price

$1.69

Analyzed by

6 Analysts

Target

$45.00

Co-Diagnostics Inc target price $45, a slight upside of 96.24% compared to current price of $1.69. According to 6 analysts rating.

Co-Diagnostics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	2	3	0	2	0	0	0	0	0
Gross Profit	0	2	0	0	2	0	0	0	0	0
Operating Income	-11	-8	-11	-10	-7	-10	-11	-8	-8	-7
EBITDA	-11	-8	-11	-9	-7	-9	-11	-8	-7	-6
Interest Expense	-	-	3	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-8	-10	-9	-7	-9	-11	-7	-7	-7
Income Tax Expense	-2	-2	3	0	0	0	0	0	0	-1
Net Income	-8	-5	-14	-9	-7	-9	-11	-7	-7	-5
Net Profit Margin	-4508.87%	-243.47%	-412.82%	-3684.36%	-286.03%	-1512.37%	-7387.37%	-14983.53%	-4745.02%	-4049.27%

Co-Diagnostics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	0	0	0	74	97	34	6	3
Gross Profit	0	0	0	0	0	57	86	28	2	2
Operating Income	-1	-1	-4	-6	-5	41	46	-26	-42	-40
EBITDA	-1	-1	-6	-6	-6	41	46	-10	-41	-38
Interest Expense	0	0	0	0	0	0	0	14	-	-
Depreciation	-	-	0	0	0	0	0	1	1	1
Income Before Tax	-2	-1	-6	-6	-6	42	45	-18	-38	-37
Income Tax Expense	-	-	0	0	0	0	8	-4	-2	0
Net Income	-2	-1	-6	-6	-6	42	36	-14	-35	-37
Net Profit Margin	-20431.68%	0.00%	-90827.88%	-15714.27%	-2882.00%	56.98%	37.45%	-41.61%	-518.68%	-961.37%

Co-Diagnostics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-5	-14	-9	-7	-9	-11	-7	-7	-5
Operating Cash Flow	-5	-4	-8	-5	-7	-8	-8	-8	-5
Investing Cash Flow	2	9	16	-4	4	0	7	17	2
Financing Cash Flow	0	0	-	-	-	0	0	0	4
Change in Cash	-3	4	8	-9	-3	-7	-1	9	0

Co-Diagnostics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-6	-6	-6	42	36	-14	-35	-37
Operating Cash Flow	-1	-3	-4	-5	28	41	6	-22	-29
Investing Cash Flow	0	0	0	0	-5	4	-58	15	17
Financing Cash Flow	2	5	1	5	19	0	-14	-1	0
Change in Cash	0	2	-2	0	42	45	-65	-8	-11

Global Institutional Holdings in Co-Diagnostics Inc

Funds	Holdings
Private Asset Group LLC	1.88%
Triton Wealth Management, PLLC	0.03%
Bank of New York Mellon Corp	0.22%
Virtu Financial LLC	0.07%
Private Asset Group LLC	3.07%

See all

Co-Diagnostics Inc News & Key Events

Insights on Co-Diagnostics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -7.73M → -5.88M (in $), with an average increase of 31.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, Co-Diagnostics Inc has experienced a drawdown of -96.2%, however Boston Scientific Corp. resisted the overall trend and outperformed by 92.3%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 9.7% return, outperforming this stock by 91.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CODX stock has moved down by -25.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 162.91K → 145.38K (in $), with an average decrease of 10.8% per quarter

About Co-Diagnostics Inc

co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are

Organisation	Co-Diagnostics Inc
Headquarters	2401 S. Foothill Dr., Salt Lake City, UT, United States, 84109
Industry	Health Technology
CEO	Mr. Dwight H. Egan
E-voting on shares	Click here to vote

Key Management of Co-Diagnostics Inc

Name	Title
Mr. Brian L. Brown CPA	CFO & Company Secretary
Mr. David Nielsen	Chief Operating Officer
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. Christopher Thurston	Chief Technology Officer
Mr. Andrew Benson	Head of Investor Relations
Dr. Mayuranki Almaula Ph.D.	Senior Vice President of Overseas Operations & Strategic Alliances
Mr. Seth Egan	Chief Commercialization Officer
Mr. Dwight H. Egan	Chairman & CEO
Mr. Richard David Abbott	President

FAQs

What is Co-Diagnostics Inc share price today?

Co-Diagnostics Inc share price today is $1.69 as on March 31, 2026 at 1:29 am IST at the close of the market. Co-Diagnostics Inc share today touched a day high of $1.8 and a low of $1.68.

What is the 52 week high and 52 week low for Co-Diagnostics Inc share?

Co-Diagnostics Inc share touched a 52 week high of $46.5 on October 27, 2025 and a 52 week low of $1.66 on March 27, 2026. Co-Diagnostics Inc stock price today i.e. March 31, 2026 at 1:29 am IST is closed at $1.69,which is 96.37% down from its 52 week high and 1.81% up from its 52 week low.

What is Co-Diagnostics Inc's market capitalisation today?

Co-Diagnostics Inc market capitalisation is $0.00T as on March 31, 2026 at 1:29 am IST.

How to invest in Co-Diagnostics Inc Stock (CODX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Co-Diagnostics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Co-Diagnostics Inc Shares that will get you 0.8876 shares as per Co-Diagnostics Inc share price of $1.69 per share as on March 31, 2026 at 1:29 am IST.

What is the minimum amount required to buy Co-Diagnostics Inc Stock (CODX) from India?

Indian investors can start investing in Co-Diagnostics Inc (CODX) shares with as little as ₹94.702 or $1 (as of March 31, 2026 at 4:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Co-Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on March 31, 2026 at 4:38 pm IST). Based on Co-Diagnostics Inc share’s latest price of $1.69 as on March 31, 2026 at 1:29 am IST, you will get 5.9172 shares of Co-Diagnostics Inc. Learn more about fractional shares .

What are the returns that Co-Diagnostics Inc has given to Indian investors in the last 5 years?

Co-Diagnostics Inc stock has given -99.41% share price returns and 29.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?